⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Senate confirms Trump's pick to run Medicare, Medicaid

Published 03/13/2017, 06:37 PM
Updated 03/13/2017, 06:40 PM
© Reuters.  Senate confirms Trump's pick to run Medicare, Medicaid

WASHINGTON (Reuters) - The U.S. Senate confirmed President Donald Trump's pick to run the government health program for the elderly, poor and disabled on Monday, filling a critical role as Republicans fight to repeal and replace Obamacare.

The Senate voted 55-43 to approve Seema Verma to run the $1 trillion Centers for Medicare and Medicaid Services. Verma is the owner of SVC Inc, a healthcare consulting firm, and has helped redesign Medicaid programs in several states, including Indiana when Vice President Mike Pence was governor.

Verma will report to U.S. Health and Human Services Secretary Tom Price.

Price and Verma are expected to make changes to many of the Medicaid and Medicare programs that were implemented under the signature legislation of former Democratic President Barack Obama, the 2010 Affordable Care Act, often called Obamacare.

Republicans unveiled their plan to repeal and replace much of Obamacare last week. The proposal would roll back an expansion of the Medicaid program for the poor and replace Obamacare's income-based tax credits with flat, age-based credits. The bill passed two House committees last week and goes to the House Budget Committee this week.

A study of the Republican healthcare measure released on Monday by the nonpartisan U.S. Congressional Budget Office found that 14 million Americans would lose medical insurance by next year if the program is approved.

It said 24 million more people would be uninsured by 2026 under the program. Price told reporters at the White House that the administration strongly disagreed with the findings, saying the CBO had not looked at the full plan to reform Obamacare.

If the Republican healthcare bill passes the House and Senate and is signed into law by Trump, Verma will play a major role in implementing the law, called the American Health Care Act.

Verma worked in Indiana to expand Medicaid to include thousands of additional low-income residents. Those residents are required to make small monthly payments toward their care through health savings accounts.

Verma's confirmation was not without controversy early on. In an initial committee hearing, Democratic Senator Ron Wyden of Oregon said that while helping manage the state of Indiana's health program, her firm was being paid by companies that were providing services and products to the program.

Verma has denied wrongdoing and said she would divest her financial interest in SVC within 90 days of confirmation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.